Aciclovir Safety During Pregnancy: What You Need to Know
NHS Guidelines for Aciclovir in Pregnancy
According to NHS guidance, aciclovir is classified as safe for use during pregnancy when clinically indicated. The medication has been extensively studied in pregnant women, with data showing no increased risk of birth defects or pregnancy complications. Healthcare professionals may prescribe aciclovir tablets during pregnancy to treat active herpes outbreaks or as suppressive therapy to reduce transmission risk during delivery.
Safety Profile and Research Evidence
Multiple studies involving thousands of pregnant women have demonstrated aciclovir's safety profile. The medication crosses the placenta in minimal amounts, and extensive registry data shows no increased risk of major malformations. Aciclovir 400mg tablets, available through EverydayMeds, represent the standard treatment dose for managing herpes infections during pregnancy. The benefits of treating active infections typically outweigh any theoretical risks, particularly in preventing neonatal transmission.
Treatment Considerations by Trimester
First trimester use requires careful consideration, though studies show no increased teratogenic risk. Second and third trimester treatment is more commonly prescribed, especially as delivery approaches. Suppressive therapy with aciclovir may be recommended from 36 weeks gestation for women with recurrent genital herpes to reduce cesarean delivery risk. Your healthcare provider will determine the most appropriate treatment timing and dosage based on your specific circumstances.
Available Treatment Options
EverydayMeds offers several aciclovir formulations suitable for pregnancy use. Aciclovir 400mg tablets provide systemic treatment for active infections, while topical aciclovir cream may be considered for localised cold sores. Alternative antiviral options like valaciclovir may also be prescribed depending on clinical needs. Professional consultation ensures appropriate medication selection and dosing throughout pregnancy.
